{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:31:46Z","timestamp":1761766306784,"version":"3.38.0"},"reference-count":32,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.nephro.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T23:50:46Z","timestamp":1513900246000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypertrophie ventriculaire gauche chez les h\u00e9modialys\u00e9s chroniques du CNHU-HKM de Cotonou"],"prefix":"10.1684","volume":"14","author":[{"given":"Jacques","family":"Vigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9raphin","family":"Ahoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Hounsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline C\u00e9line Kp\u00e8hou\u00e9do","family":"Goudot\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Vehounkpe Sacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2017.06.001_bib0005","first-page":"541","article-title":"Exploration cardiaque chez l\u2019h\u00e9modialys\u00e9 et le transplant\u00e9 r\u00e9nal","volume":"1","author":"Beygui","year":"2005","journal-title":"MT Cardio"},{"key":"10.1016\/j.nephro.2017.06.001_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/S0066-782X2012005000004","article-title":"Ventricular hypertrophy and cardiovascular mortality in hemodialysis patients with low eductional level","volume":"98","author":"Martin","year":"2012","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.nephro.2017.06.001_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCIMAGING.111.969923","article-title":"Determinants of left ventricular mass in patients on hemodialysis: frequent hemodialysis network (FHN) trials","volume":"5","author":"Chan","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nephro.2017.06.001_bib0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000326239","article-title":"Left ventricular mass index as an outcome measure in clinical trials in dialysis patients: a word of caution","volume":"33","author":"Zoccali","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2017.06.001_bib0025","first-page":"228","article-title":"Risque cardiovasculaire dans l\u2019insuffisance r\u00e9nale chronique","volume":"573","author":"L\u00e9vy","year":"2003","journal-title":"Rev Med suisse"},{"key":"10.1016\/j.nephro.2017.06.001_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.001_bib0035","first-page":"359","article-title":"Pathologies cardiovasculaires de l\u2019insuffisance r\u00e9nale chronique terminale, aspect \u00e9pid\u00e9miologique","volume":"23","author":"Kessler","year":"2002","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2017.06.001_bib0040","first-page":"290","article-title":"Pr\u00e9valence et facteurs pr\u00e9dictifs de survenue d\u2019une hypertrophie ventriculaire gauche en h\u00e9modialyse chronique","volume":"9","author":"Karimi","year":"2013","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2017.06.001_bib0045","first-page":"1","article-title":"\u00c0 propos de l\u2019h\u00e9modialyse quotidienne","volume":"25","author":"Traeger","year":"2004","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2017.06.001_bib0050","first-page":"25","article-title":"Echocardiographic data from chronic dialysis patients in Dakar","volume":"42","author":"Kane","year":"1997","journal-title":"Dakar Med"},{"key":"10.1016\/j.nephro.2017.06.001_bib0055","first-page":"859","article-title":"Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation","volume":"16","author":"Ulasi","year":"2006","journal-title":"Ethn Dis"},{"key":"10.1016\/j.nephro.2017.06.001_bib0060","article-title":"Guide pratique de l\u2019ECG","author":"Sende","year":"2009","journal-title":"Estem"},{"key":"10.1016\/j.nephro.2017.06.001_bib0065","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and Standards committee and the chamber quantification writing grup","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.nephro.2017.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013\u00a0ESH\/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.nephro.2017.06.001_bib0075","first-page":"1133","article-title":"Hypertrophie ventriculaire gauche chez les h\u00e9modialys\u00e9s chroniques","volume":"22","author":"El M\u2019Barki","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.nephro.2017.06.001_bib0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nephro.2011.07.136","article-title":"\u00c9valuation des facteurs de risque cardiovasculaire chez nos h\u00e9modialys\u00e9s chroniques selon les recommandations de la K\/DOQI","volume":"7","author":"Adlouni","year":"2011","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2017.06.001_bib0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/aor.12156","article-title":"Impact of dry weight determined by calf bioimpedance ratio on carotid stiffness and left ventricular hypertrophy in haemodialysis patients","volume":"38","author":"Zhou","year":"2014","journal-title":"Artificial Organs"},{"key":"10.1016\/j.nephro.2017.06.001_bib0090","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ki.1996.194","article-title":"Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease","volume":"49","author":"Foley","year":"1996","journal-title":"Kidney Int"},{"year":"2000","series-title":"L\u2019\u00e9lectrocardiogramme\u00a0: guide pratique","author":"Algazi","key":"10.1016\/j.nephro.2017.06.001_bib0095"},{"key":"10.1016\/j.nephro.2017.06.001_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","article-title":"Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention","volume":"27","author":"Levin","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.06.001_bib0105","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.001_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000057427","article-title":"Left ventricular hypertrophy in daily dialysis","volume":"25","author":"Buoncristiani","year":"1999","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.nephro.2017.06.001_bib0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/ajkd.2001.26103","article-title":"Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients","volume":"38","author":"Fagugli","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.06.001_bib0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1525-1594.1998.06213.x","article-title":"Daily versus standard hemodialysis: 1-year experience","volume":"22","author":"Traeger","year":"1998","journal-title":"Artif Organs"},{"key":"10.1016\/j.nephro.2017.06.001_bib0125","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1046\/j.1523-1755.2002.00362.x","article-title":"Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis","volume":"6","author":"Chan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.001_bib0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ndt\/14.2.369","article-title":"Fluid state and blood pressure control in patients treated with long and short hemodialysis","volume":"14","author":"Katzarski","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.06.001_bib0135","first-page":"1","article-title":"The association of long-functioning hemodialysis vascular access with prevalence of left ventricular hypertrophy in kidney transplant recipients","author":"Kolonko","year":"2014","journal-title":"Bio Med Res Int"},{"key":"10.1016\/j.nephro.2017.06.001_bib0140","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3923\/pjbs.2005.1623.1627","article-title":"Effect of anemia on left ventricular hypertrophy and ejection fraction in maintenance hemodialysis patients","volume":"8","author":"Baradaran","year":"2005","journal-title":"Pakistan J Biol Sci"},{"key":"10.1016\/j.nephro.2017.06.001_bib0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s10157-012-0705-4","article-title":"Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents","volume":"17","author":"Hayashi","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nephro.2017.06.001_bib0150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.06.001_bib0155","first-page":"318","article-title":"Prevalence and clinical consequences of elevated Ca x\u00a0P product in hemodialysis patients","volume":"54","author":"Block","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2017.06.001_bib0160","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x\u00a0PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517305588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517305588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.06.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:09:01Z","timestamp":1741190941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517305588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1769725517305588"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.06.001","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophie ventriculaire gauche chez les h\u00e9modialys\u00e9s chroniques du CNHU-HKM de Cotonou","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}